Eisai U.S. Subsidiary To Work With Forma For Drug Discoveries
This article was originally published in PharmAsia News
Executive Summary
Eisai's U.S. unit and American drug maker Forma Therapeutics have reached an agreement to collaborate on discovering new compounds